我国由患者自控镇痛到自主创新智能化产品临床应用研究的发展历程  

The development course of clinical application research from patient-controlled analgesia to independent innovative intelligent products in China

作　　者：佘守章[1] She Shouzhang(Department of Anesthesiology,Guangzhou First People's Hospital,Guangzhou City,Guangdong Province 510180,China)

机构地区：[1]广州市第一人民医院手术麻醉中心,广州市510180

出　　处：《中华疼痛学杂志》2023年第1期167-172,共6页Chinese Journal Of Painology

摘　　要：本文回顾我国患者自控镇痛(PCA)到智能化患者自控镇痛(Ai-PCA)临床应用研究的发展历程, 以期让读者对我国镇痛治疗历史有一个更清晰地了解。由PCA发展到自主创新Ai-PCA是现代医学完善疼痛治疗不可忽视的刚性需求, 应推动中国临床自控镇痛技术向智慧化发展。This paper reviews the development course of clinical application research from patient-controlled analgesia(PCA)treatment to artificial intelligence patient-controlled analgesia(Ai-PCA),to provide the readers with a clearer understanding of the history of postoperative analgesia treatment in China.The development from PCA to autonomous innovation of Ai-PCA is a rigid demand that cannot be ignored in modern medicine to perfect pain treatment,and the development of clinical self-controlled analgesia technology to wisdom analgesia should be promoted in China.

关 键 词：人工智能 镇痛 病人控制 医学历史 

分 类 号：R614[医药卫生—麻醉学]